서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 13 of 13

Issue DateTitle / Author(s) / CitationFileAltmetrics
2005-06
Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country
link
2006-10
Cost of treatment for multidrug-resistant tuberculosis in South Korea
link
2006-12
The prevalence and evolution of anemia associated with tuberculosis
view filelink
2007-05
Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis
link
2016-12
Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions
DOI
2018-04
Regional differences in the incidence of tuberculosis among patients with newly diagnosed diabetes mellitus

Yang, Bo Ram; Kang, Young Ae; Heo, Eun Young; Koo, Bo Kyung; Choi, Nam-Kyong; Hwang, Seung-Sik; Lee, Chang-Hoon

Clinical Respiratory Journal, Vol.12 No.4, pp.1732-1738

DOI
2019-01
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
view fileDOI
2021
방글라데시 의료기관의 만성질환 의료서비스 준비상태 영향 요인 분석
view filelink
2022-08
Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial
DOI
2022-08
Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial
view filelink
2023-01
Healthcare use and medical cost before and after diagnosis of nontuberculous mycobacterial infection in Korea: the National Health Insurance Service-National Sample Cohort Study

Lee, Seung Won; Chang, Shihwan; Park, Youngmok; Kim, Sol; Sohn, Hojoon; Kang, Young Ae

Therapeutic Advances in Respiratory Disease, Vol.17, p. 1

DOI
2023-11
Real-world impact of the fixed-dose combination on improving treatment outcomes of drug-susceptible tuberculosis: a comparative study using multiyear national tuberculosis patient data

Ki, Min Seo; Jeong, Dawoon; Kang, Hee-Yeon; Choi, Hongjo; Sohn, Hojoon; Kang, Young Ae

BMJ Open Respiratory Research, Vol.10 No.1, p. e001758

DOI
2024-04
Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort
DOI
1